FindTrial
Sign In

Effect of nalbuphine combined with ropivacaine transversus abdominis plane block on analgesia and gastrointestinal function recovery after laparoscopic radical resection of gastrointestinal cancer

Effect of nalbuphine combined with ropivacaine transversus abdominis plane block on analgesia and gastrointestinal function recovery after laparoscopic radical resection of gastrointestinal cancer

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400094399
Enrollment
Unknown
Registered
2024-12-23
Start date
2024-04-01
Completion date
Unknown
Last updated
2025-01-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Carcinoma of colon

Interventions

Group B:Nalbuphine combined with ropivacaine bilateral transversus abdominis plane block
Group A:Ropivacaine bilateral transversus abdominis plane block

Sponsors

Youjiang medical university for nationalities
Lead Sponsor

Eligibility

Sex/Gender
All
Age
35 Years to 75 Years

Inclusion criteria

Inclusion criteria: (1) Patients with American Society of Anesthesiologists (ASA) grade I and II; (2) Age 35-75 years old; (3)BMI18.5-26 kg/m^2.

Exclusion criteria

Exclusion criteria: (1) Patients with dysfunction of important organs; (2) Patients with a history of previous abdominal surgery; (3) Patients with a history of local anesthetic and opioid allergy in the past.

Design outcomes

Primary

MeasureTime frame
Cortisol;Motilin;Gastrin;Systolic pressure;Heart rate;Diastolic pressure;Gastric inhibitory polypeptide;Visual analogue scale;Ramsay sedation score;—

Countries

China

Contacts

Public ContactLi Huiling

Youjiang Medical University for Nationalities

1102374452@qq.com+86 157 7836 1989

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026